These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36614962)

  • 1. Vertebral Fractures in Acromegaly: A Systematic Review.
    Sorohan MC; Poiana C
    J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36614962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis.
    Ribeiro de Moura C; Campos Lopes S; Monteiro AM
    Pituitary; 2022 Dec; 25(6):780-794. PubMed ID: 35867180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trabecular Bone Score as an Index of Bone Fragility in Patients with Acromegaly: A Systematic Review and Meta-Analysis.
    Bioletto F; Barale M; Prencipe N; Berton AM; Parasiliti-Caprino M; Gasco V; Ghigo E; Procopio M; Grottoli S
    Neuroendocrinology; 2023; 113(4):395-405. PubMed ID: 36617407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of vertebral fractures and serum sclerostin levels in acromegaly.
    Uygur MM; Yazıcı DD; Buğdaycı O; Yavuz DG
    Endocrine; 2021 Sep; 73(3):667-673. PubMed ID: 34019235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly.
    Wassenaar MJ; Biermasz NR; Hamdy NA; Zillikens MC; van Meurs JB; Rivadeneira F; Hofman A; Uitterlinden AG; Stokkel MP; Roelfsema F; Kloppenburg M; Kroon HM; Romijn JA; Pereira AM
    Eur J Endocrinol; 2011 Apr; 164(4):475-83. PubMed ID: 21257726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone histomorphometry in acromegaly patients with fragility vertebral fractures.
    Dalle Carbonare L; Micheletti V; Cosaro E; Valenti MT; Mottes M; Francia G; Davì MV
    Pituitary; 2018 Feb; 21(1):56-64. PubMed ID: 29214508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly.
    Chiloiro S; Mazziotti G; Giampietro A; Bianchi A; Frara S; Mormando M; Pontecorvi A; Giustina A; De Marinis L
    Pituitary; 2018 Jun; 21(3):302-308. PubMed ID: 29397538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vertebral fracture assessment in acromegaly.
    Madeira M; Neto LV; Torres CH; de Mendonça LM; Gadelha MR; de Farias ML
    J Clin Densitom; 2013; 16(2):238-43. PubMed ID: 22884713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trabecular Bone Score as a Reliable Measure of Lumbar Spine Bone Microarchitecture in Acromegalic Patients.
    Nazzari E; Casabella A; Paolino S; Campana C; Corica G; Nista F; Milioto A; Tagliafico A; Albertelli M; Boschetti M; Bagnasco M; Cutolo M; Ferone D; Gatto F
    J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women.
    Bonadonna S; Mazziotti G; Nuzzo M; Bianchi A; Fusco A; De Marinis L; Giustina A
    J Bone Miner Res; 2005 Oct; 20(10):1837-44. PubMed ID: 16160741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DXA-derived lumbar bone strain index corrected for kyphosis is associated with vertebral fractures and trabecular bone score in acromegaly.
    Jaafar S; Cristofolini G; Morenghi E; Rinaudo L; Birtolo MF; Sala E; Ferrante E; Mungari R; Lavezzi E; Leonardi L; Ragucci P; Ulivieri FM; Balzarini L; Mantovani G; Lania AG; Mazziotti G
    Endocrine; 2024 May; ():. PubMed ID: 38809345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of vertebral fractures in men with acromegaly.
    Mazziotti G; Bianchi A; Bonadonna S; Cimino V; Patelli I; Fusco A; Pontecorvi A; De Marinis L; Giustina A
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4649-55. PubMed ID: 18827004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of vertebral fractures despite long-term biochemical control of acromegaly: a prospective follow-up study.
    Claessen KM; Kroon HM; Pereira AM; Appelman-Dijkstra NM; Verstegen MJ; Kloppenburg M; Hamdy NA; Biermasz NR
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4808-15. PubMed ID: 24081732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trabecular bone score and bone mineral density in patients with long-term controlled acromegaly.
    Calatayud M; Pérez-Olivares Martín L; Librizzi MS; Lora Pablos D; González Méndez V; Aramendi Ramos M; Martínez Diaz-Guerra G; Hawkins F
    Clin Endocrinol (Oxf); 2021 Jul; 95(1):58-64. PubMed ID: 33559169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conventional X-rays in the diagnosis and follow-up of vertebral fractures in patients with acromegaly: a real-life study.
    Sardella C; Urbani C; Marconcini G; Cappellani D; Manetti L; De Liperi A; Romei C; Morganti R; Marcocci C; Bogazzi F
    J Endocrinol Invest; 2024 Feb; 47(2):325-334. PubMed ID: 37668886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise for improving outcomes after osteoporotic vertebral fracture.
    Gibbs JC; MacIntyre NJ; Ponzano M; Templeton JA; Thabane L; Papaioannou A; Giangregorio LM
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD008618. PubMed ID: 31273764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Acromegalic Osteopathy in Real-life Clinical Practice: The BAAC (Bone Active Drugs in Acromegaly) Study.
    Mazziotti G; Battista C; Maffezzoni F; Chiloiro S; Ferrante E; Prencipe N; Grasso L; Gatto F; Olivetti R; Arosio M; Barale M; Bianchi A; Cellini M; Chiodini I; De Marinis L; Del Sindaco G; Di Somma C; Ferlin A; Ghigo E; Giampietro A; Grottoli S; Lavezzi E; Mantovani G; Morenghi E; Pivonello R; Porcelli T; Procopio M; Pugliese F; Scillitani A; Lania AG
    J Clin Endocrinol Metab; 2020 Sep; 105(9):. PubMed ID: 32511698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of morphometric vertebral fractures in "difficult" patients with acromegaly with different biochemical outcomes after multimodal treatment.
    Chiloiro S; Mormando M; Bianchi A; Giampietro A; Milardi D; Bima C; Grande G; Formenti AM; Mazziotti G; Pontecorvi A; Giustina A; De Marinis L
    Endocrine; 2018 Feb; 59(2):449-453. PubMed ID: 28836162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exon 3-deleted growth hormone receptor isoform is not related to worse bone mineral density or microarchitecture or to increased fracture risk in acromegaly.
    Pontes J; Madeira M; Lima CHA; Ogino LL; de Paula Paranhos Neto F; de Mendonça LMC; Farias MLF; Kasuki L; Gadelha MR
    J Endocrinol Invest; 2020 Feb; 43(2):163-171. PubMed ID: 31392573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GH receptor isoforms and skeletal fragility in acromegaly.
    Mormando M; Nasto LA; Bianchi A; Mazziotti G; Giampietro A; Pola E; Pontecorvi A; Giustina A; De Marinis L
    Eur J Endocrinol; 2014 Aug; 171(2):237-45. PubMed ID: 24866575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.